BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2399692)

  • 61. Discrepant in vitro versus in vivo interaction of M-positive donor red cells with IgG1 anti-M.
    Branch DR; McBroom R; Jones GL
    Rev Fr Transfus Immunohematol; 1983 Dec; 26(6):565-72. PubMed ID: 6675157
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay.
    Nance SJ; Arndt P; Garratty G
    Transfusion; 1987; 27(6):449-52. PubMed ID: 3686653
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units.
    Baldwin ML; Ness PM; Barrasso C; Kickler TS; Drew H; Tsan MF; Shirey RS
    Transfusion; 1985; 25(1):34-8. PubMed ID: 3969699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anticomplement and the indirect antiglobulin test.
    Wright MS; Issitt PD
    Transfusion; 1979; 19(6):688-94. PubMed ID: 118556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A newly developed gel centrifugation test for quantification of RBC-bound IgG antibodies and their subclasses IgG1 and IgG3: comparison with flow cytometry.
    Lynen R; Krone O; Legler TJ; Köhler M; Mayr WR
    Transfusion; 2002 May; 42(5):612-8. PubMed ID: 12084170
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reduced survival of isotope-labelled Rh(D)-negative donor red cells in a patient with anti-LWab.
    Herron R; Bell A; Poole J; Clark M; Smith DS; Hamblin TJ
    Vox Sang; 1986; 51(4):314-7. PubMed ID: 3099473
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of human blood monocytes in erythrophagocytosis assay with anti-Rh antibodies.
    Brojer E; Gronkowska A; Zupańska B
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):553-60. PubMed ID: 3496064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies.
    Freedman J; Massey A; Chaplin H; Monroe MC
    Br J Haematol; 1980 Jun; 45(2):309-18. PubMed ID: 6776980
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of an anti-Dia antibody causing hemolytic disease in a newborn infant.
    Alves de Lima LM; Berthier ME; Sad WE; DiNapoli J; Johnson CL; Marsh WL
    Transfusion; 1982; 22(3):246-7. PubMed ID: 7090038
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 71. IgG subclasses of anti-Rh antibodies in pregnant women.
    Frankowska K; Górska B
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1095-100. PubMed ID: 107909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Eluate testing following microscopically positive direct antiglobulin tests with anti-IgG.
    Richa E; Benidt G; Tauscher C; Stowers R; Bryant S; Stubbs J
    Ann Clin Lab Sci; 2007; 37(2):167-9. PubMed ID: 17522373
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Complement is not activated in ABO-haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Huiskes E; Bos MJ; Ouwehand WH; Engelfriet CP
    Br J Haematol; 1988 Mar; 68(3):363-6. PubMed ID: 3258530
    [TBL] [Abstract][Full Text] [Related]  

  • 74. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
    Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
    Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Optimal conditions for the performance of a monocyte monolayer assay.
    Tong TN; Burke-Murphy E; Sakac D; Pendergrast J; Cserti-Gazdewich C; Laroche V; Branch DR
    Transfusion; 2016 Nov; 56(11):2680-2690. PubMed ID: 27546234
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Case report: Severe hemolytic disease of the fetus and newborn due to anti-C+G.
    Jernman R; Stefanovic V; Korhonen A; Haimila K; Sareneva I; Sulin K; Kuosmanen M; Sainio S
    Immunohematology; 2015; 31(3):123-7. PubMed ID: 26829179
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation.
    Valenzuela NM; Schaub S
    Transplantation; 2018 Jan; 102(1S Suppl 1):S7-S13. PubMed ID: 29266057
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A major role of class I Fc gamma receptors in immunoglobulin G anti-D-mediated red blood cell destruction by fetal mononuclear phagocytes.
    Wiener E; Mawas F; Dellow RA; Singh I; Rodeck CH
    Obstet Gynecol; 1995 Aug; 86(2):157-62. PubMed ID: 7617343
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rapid detection of IgG subclasses on DAT positive RBC membranes by flow cytometry (FC).
    Asmussen C; Gutensohn K; Wittkopf D; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1996; 33():35-9. PubMed ID: 8865935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.